Panacea Venture
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Growth, Seed
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, India, Brazil, France, Italy, Denmark, Switzerland, Spain, Mexico, South Korea, Bangladesh, Netherlands, South Africa, Russia, Sweden, Belgium, Norway, Finland, Poland, Taiwan, Kyrgyzstan
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Medical Research
- Regenerative Medicine
- Immunotherapy
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Infectious Diseases
- Immunology
- Genomics
- Women's Health
- Rare Diseases
- Health IT
- Orthopedics
- Autoimmune Diseases
- Pulmonology
- Cardiovascular Diseases
- Neurodegenerative Diseases
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2017
Panacea Venture is a life sciences venture capital firm with a global vision and reach, dedicated to transforming lives through promising innovation. Spun out from Kleiner Perkins, the founding partners sought to build a global firm, investing in innovation across various geographies, while bringing their unique perspectives and life sciences expertise to benefit global company building. To date, Panacea Venture has raised three USD funds from renowned institutional funds as well as strategic investors and has investments in more than 30 private companies and several public companies.
The firm specializes in building innovative and transformative early and growth-stage healthcare and life science companies globally. Their forward-looking and adaptive investment strategy anticipates industry and policy trends, adjusting accordingly to optimize their competitive advantage. Panacea Venture invests across the sub-sectors of life sciences, across geography and development stage, while leveraging their unique cross-functional talent base to create value from company formation all the way to public market investing.
Panacea Venture is comprised of 19 Partners, Venture Partners, and advisors. The team operates across three continents and represents a diverse skill base ranging from entrepreneurs to industry function expertise, including clinical development, regulatory, commercial analysis, and business development. Their highly experienced investment partners have greater than 100 years of combined investing experience, and along with their venture partners and advisors, have collective experience in emerging and established biotech/diagnostic/medtech, global multinational companies, and key regulatory agencies such as the FDA.
Requirements
- Innovative technologies addressing unmet medical needs
- Early-stage healthcare and life science companies
- Global market potential
- Experienced management teams
- Scalable business models
- Strong intellectual property portfolios
- Regulatory compliance
- Clear exit strategies
- Alignment with Panacea Venture's investment thesis
- Commitment to improving quality of life through healthcare advancements
- Innovative and transformative healthcare and life science technologies
- Early and growth stage companies
- Strong intellectual property portfolio
- Clear regulatory pathway
- Scalable business model
- Potential for significant impact on patient care and outcomes
- Alignment with Panacea Venture's investment strategy and values
- Ability to attract additional funding and partnerships
- Innovative life science technologies addressing unmet medical needs
- Strong management teams with a track record of success
- Potential for global market impact
- Clear regulatory pathways
- Competitive differentiation in the market
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Actym Therapeutics
- Domain Therapeutics
- OutSee
- Evox Therapeutics
- Myrtelle
- HanchorBio
- Inmagene Biopharmaceuticals
- Zhaoke Ophthalmology
- Human Longevity, Inc.
- Biosplice Therapeutics
- CureMetrix
- Day Zero Diagnostics
- Ignota Labs
- CardiaTec
- Axiom Therapeutics
- MitoRx Therapeutics
- Sixfold Bioscience
- Sava Health
- Refael Michali
- Renato Circi
- Mytos
- Ignacio Wilats
- Ali Afshar
- DJS Antibodies
- Enterobiotix
- Phenomic AI
Mentioned In
-
$19.95
-
$49.95
-
$9.95
-
$14.95
-
$39.95
-
$19.95
-
$24.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Panacea Venture?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim